This study, for the first time, uncovers the underlying mechanism by which Mxi1 suppresses lung cancer progression, imparting an improved understanding of the pathogenesis of lung cancer and providing novel potential therapeutic targets for lung cancer treatment. This evidence concerns the gene MXI1 and lung carcinoma.